A top official at the DEA, Department of Health and Human Services has called for marijuana to be reclassified as a lower Schedule III drug under the Controlled Substances Act

The U.S. Health and Human Services Department has suggested a reclassification of marijuana to a lower-risk drug category, a move that could potentially ease restrictions on the cannabis industry, according to a Drug Enforcement Agency (DEA) spokesperson's statement to CNBC on Wednesday.

Currently categorized as a Schedule I drug under the Controlled Substances Act, marijuana is considered to lack accepted medical use and possess a high potential for abuse. Despite being legalized for recreational purposes in nearly half of the U.S. states, its federal classification alongside substances like heroin and LSD has hindered the industry's expansion.

As the cannabis industry saw a surge in sales during the pandemic, it is now facing a decline due to dwindling investor interest and capital availability. Stringent federal regulations have also denied most banking services to the industry and restricted cross-state trading, leading to an oversupply of cannabis in various states and a decrease in prices.

A federal reclassification could potentially broaden the market for marijuana, which is already a multibillion-dollar industry in the U.S. and a significant crop in newly legalized states.

News of this recommendation led to a rise in the shares of several cannabis companies, including Canopy Growth, Tilray Brands, and Cronos Group. The Health and Human Services Department proposed that marijuana should be reclassified as a Schedule III drug under the Controlled Substances Act in a letter to DEA officials. Schedule III drugs have a moderate to low potential for physical and psychological dependence.

While the DEA holds the ultimate authority to reschedule controlled substances, it will now initiate a review process for marijuana in light of this recommendation.

tastytrade logo+
Get the best broker for options trading and earn Unusual Whales discounted! in cash with an eligible account deposit at tastytrade. Get an Unusual Whales bonus when you deposit $2000. Offer expires 3/31/25. Certain restrictions, terms and conditions apply.
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.